Clinical Trials Logo

Clinical Trial Summary

The purpose of this trial is to evaluate the clinical efficacy, the cost-effectiveness and the 6-month durability of a therapist-guided, Internet-delivered cognitive-behavior therapy programme for children and adolescents with body dysmorphic disorder.


Clinical Trial Description

Primary objective: To determine the clinical efficacy of a therapist-guided, Internet-delivered cognitive-behaviour therapy (ICBT) programme for body dysmorphic disorder (BDD) in reducing BDD symptom severity in children and adolescents with BDD, compared to a control intervention consisting of a therapist-guided, Internet-delivered relaxation treatment (IRT) for BDD. Secondary objective: To establish the 6-month durability of the treatment effects and to assess the cost-effectiveness of ICBT, compared with IRT, from multiple perspectives and to conduct a health-economic evaluation of ICBT for BDD at the primary endpoint from a health organisation payer, healthcare resource use, and societal perspective. Type of trial: A multisite parallel-group randomised controlled superiority trial. Rationale: BDD is a prevalent and impairing disorder that tends to have a chronic course if left untreated. Adolescent-onset BDD is associated with more severe symptoms, greater lifetime comorbidity, and higher rates of attempted suicide compared to adult-onset BDD. Therefore, early intervention is crucial. BDD can be effectively treated with cognitive-behaviour therapy (CBT), although the current evidence is rather weak and more evidence is needed. Furthermore, CBT for BDD is a highly specialised treatment and many young people do not have access to it. ICBT can be a way to increase the availability of an effective, evidence-based treatment for children and adolescents with BDD. Trial design and methods: Participants will be recruited nationally across Sweden and will be offered 12 modules of therapist-guided ICBT or 12 modules of therapist-guided IRT delivered over 12 weeks. Under certain circumstances, such as illness or holidays, the design allows participants to pause their therapist-support for a maximum of two weeks, which may extend the treatment length to a maximum of 14 weeks. All potential participants will be initially screened via the telephone or at one of the three participating sites. This will be followed by an inclusion/baseline assessment conducted either at one of the three clinics (BUP OCD och relaterade tillstånd, BUP Specialmottagning or BUP Skåne) or, if face-to-face assessments are not feasible, via a secure video application. Participants who are eligible and have consented will be randomised to one of two trial arms. Participants in the comparator group (IRT) will be offered to cross-over to the ICBT intervention after the primary endpoint. The primary outcome variable: The primary outcome variable is BDD symptom severity measured by the Yale-Brown Obsessive Compulsive Scale modified for BDD, Adolescent version (BDD-YBOCS-A) at the primary endpoint (1-month follow-up post-treatment). Based on BDD-YBOCS-A scores, responder and remission rates at all follow-up points will be calculated. Response will be defined as ≥30% reduction from baseline; full or partial remission will be defined as a score ≤16. Planned trial sites: The study will be coordinated from the Department of Clinical Neuroscience at Karolinska Institutet (the Sponsor). There will be 3 collaborating study sites: BUP OCD och relaterade tillstånd (Region Stockholm), BUP Specialmottagning (Västra Götalandsregionen), and BUP Skåne (Region Skåne). Each of the three sites will assess and treat participants from their own region, and occasionally from adjacent regions. Sample: A total of 154 children and adolescents diagnosed with BDD and their primary caregivers. Statistical methodology and analysis: Data will be analysed using a pre-specified intention-to-treat statistical analysis plan. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06262412
Study type Interventional
Source Karolinska Institutet
Contact Lorena Fernández de la Cruz, PhD
Phone +46 76 847 79 99
Email lorena.fernandez.de.la.cruz@ki.se
Status Recruiting
Phase N/A
Start date February 19, 2024
Completion date October 31, 2026

See also
  Status Clinical Trial Phase
Completed NCT02524301 - Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study N/A
Completed NCT05078320 - Internet-delivered Cognitive-behaviour Therapy for Adolescents With Body Dysmorphic Disorder N/A
Recruiting NCT03918577 - Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders N/A
Completed NCT01398904 - Attentional Bias in Body Dysmorphic Disorder N/A
Completed NCT03773549 - A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder
Recruiting NCT05607121 - TMS Visual Modulation in Body Dysmorphic Disorder N/A
Completed NCT03221738 - Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder N/A
Completed NCT04254575 - Understanding Daily Changes in BDD Risk Using Smartphones
Completed NCT04103606 - A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students N/A
Recruiting NCT01093950 - White Light Scanning to Aid Body Contouring: A Pilot Project N/A
Recruiting NCT04899687 - Study of Dextromethorphan in OCD and Related Disorders Phase 2
Completed NCT05612425 - Text Message Safety Behavior Fading for Appearance Concerns N/A
Completed NCT06370559 - Relationship Between Repetitive Negative Thinking and CBT Outcomes
Completed NCT04656301 - Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Phase 2
Active, not recruiting NCT04034693 - Waitlist-Control Trial of Smartphone CBT for Body Dysmorphic Disorder (BDD) N/A
Recruiting NCT06346301 - Imagery Rescripting as a Stand-alone Treatment for OCD and BDD. N/A
Recruiting NCT01316627 - Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions Phase 2
Completed NCT03517384 - Feasibility Pilot Study of Internet-based Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder With Global Recruitment N/A